Sandeep Menon's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 441,350 Emp. Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharma Inc | Sandeep Menon | Chief R&D Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2026 | 441,350 | 441,350 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Sandeep Menon | Chief R&D Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2026 | 205,150 | 205,150 (0%) | 0% | 0 | Common Stock |